ENANTA PHARMACEUTICALS INC (ENTA) has 90 open-market insider trades by 27 insiders since 2013. The most active filer is Nathalie Adda, VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Helmut Schuhsler | 10% | — | 4 | $21.8M | 2014-03-04 |
| V. Life Science Ventures Management GmbH & Co. Kg Tvm | 10% | — | 1 | $17.1M | 2014-03-04 |
| Nathalie Adda | VP | — | 12 | $14.7M | 2022-04-04 |
| Jay R. Luly | CEOPres | — | 9 | $10.7M | 2026-02-12 |
| Yat Sun Or | CSOVP | — | 10 | $9.2M | 2026-02-12 |
| Hubert Birner | 10% | — | 1 | $9.0M | 2014-02-26 |
| (Adjunct) Iii - Holdings Llc Obp | 10% | — | 1 | $4.7M | 2013-10-01 |
| Tim Ocain | PresVP | — | 2 | $4.2M | 2019-02-12 |
| Paul J. Mellett | CFOTreasurer | — | 8 | $4.1M | 2025-02-12 |
| George Golumbeski | Dir | — | 4 | $3.4M | 2019-03-04 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Scott T. Rottinghaus | Chief Medical Officer | Sell | $11K | 2025-12-05 |
| Yat Sun Or | Chief Scientific Officer | Sell | $34K | 2025-12-05 |
| Jay R. Luly | CEO & President | Sell | $135K | 2025-12-05 |
| Kathleen S. Capps | — | Sell | $5K | 2025-12-05 |
| Tara Lynn Kieffer | Chief Product Strategy Officer | Sell | $30K | 2025-12-05 |
| Brendan Luu | Chief Business Officer | Sell | $20K |
Companies that share insiders with ENTA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-12-05 |
| Harry R. Trout III | — | Sell | $8K | 2025-12-05 |
| Kathleen S. Capps | — | Sell | $3K | 2025-12-02 |
| Harry R. Trout III | — | Sell | $5K | 2025-12-02 |
| Jay R. Luly | CEO & President | Buy | $512K | 2025-02-12 |
| Brendan Luu | Chief Business Officer | Sell | $18K | 2024-12-06 |
| Scott T. Rottinghaus | Chief Medical Officer | Sell | $7K | 2024-12-06 |
| Jay R. Luly | President | Sell | $41K | 2024-12-06 |
| Yat Sun Or | Chief Scientific Officer | Sell | $21K | 2024-12-06 |
| Scott T. Rottinghaus | — | Sell | $347K | 2024-07-11 |